The company expired its plan on June 23, 2022.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+26.78% | 661B | |
+27.43% | 566B | |
-6.41% | 352B | |
+20.60% | 332B | |
+2.46% | 283B | |
+13.76% | 231B | |
+5.16% | 200B | |
-9.12% | 195B | |
-5.00% | 145B |